What this topic covers
ADC papers span oncology, medicinal chemistry, tumor biology, pharmacology, companion diagnostics, adverse events, and treatment sequencing.
Topic feed
Recent Antibody Drug Conjugate Papers
Browse new antibody drug conjugate research across targets, payloads, linker chemistry, resistance mechanisms, toxicities, biomarkers, and clinical development.
How to use this feed
Start with antibody drug conjugate, then refine with ADC target names, payload classes, HER2, TROP2, B7-H3, toxicity, resistance, or by cancer type.
Search ideas
Useful searches to try next
Research context
How to read this topic
What signals are most useful?
Target selection, payload class, linker stability, patient selection, response biomarkers, and safety signals are the key patterns to watch.
Why include preprints?
Preprints can surface target biology, linker engineering, and resistance studies before they appear in clinical review literature.